<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SII-40144</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Genomma Lab</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">- Increased access to quality and affordable of pharmaceuticals and personal care products in the LAC region: The Company&apos;s existing distribution network enables Genomma to deliver quality and affordable over-the-counter (OTC) medicines and personal care products to thousands of stores, including mom &amp; pops stores, increasing the availability of medicines to often lower income populations who frequent these stores. With the new manufacturing plant, Genomma will be able increase better control quality and manage its production levels, while lowering its production costs, and thus able to offer more affordable personal care and OTC pharmaceuticals.

- Employment generation and development of SMEs: With the new plant and distribution center Genomma expects to generate over 300 direct new jobs in small communities of the state of Mexico during and after construction phase, including female employment. The Project will also bring indirect employment through the Company&apos;s purchases of goods and services. Genomma works with c. 80 direct suppliers and c. 240 indirect SMEs/suppliers

- Free up public health system&apos;s resources: OTC medicines are an important cost saving tool for government health spending by reducing the number of visits to a doctor for a prescription and reducing prescription drugs costs. OTC medicines provide consumers safe and effective treatments for commonly occurring conditions, saving the patient time and leaving doctor consultation slots open to those for need these</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">p.cls-NormalWeb {
    margin-top:0pt;
    margin-bottom:0pt;
    text-align:justify;
    font-family:&apos;Times New Roman&apos;, &apos;serif&apos;;
    font-size:12pt;
    line-height:108%;
    margin-left:0pt;
    margin-right:0pt;
}
span.cls-DefaultParagraphFont {
    font-family:&apos;Times New Roman&apos;, &apos;serif&apos;;
    font-size:12pt;
    font-weight:normal;
    margin:0in;
    padding:0in;
}
span.cls-000000 {
    font-size:12pt;
    font-weight:normal;
    margin:0in;
    padding:0in;
}
table { border-collapse:collapse !important; width:100%; table-layout:fixed; border-spacing:0 !important; margin-bottom:15px; } .k-table, .k-table td, table, table td, div table, div table td {outline: 0;border: 1px solid #000;} .k-table td, table td, div table td { padding: 5px;} 
  
  
     
       
         Founded in 1996, Genomma Lab Internacional S.A.B. de C.V. (&quot;Genomma&quot; or the Company) is a Mexico-based, pharmaceutical company listed in the Mexican Stock Exchange with a presence in 18 countries across Latin America, and in the U.S.. It is focused on the marketing, distribution and sales of over-the-counter (OTC) or non-prescription medicines and personal care products. Genomma uses third-party contract manufacturers to manufacture its products, 90 percent of which are manufactured in Mexico). &#xA0; 
       
       
         &#xA0; 
       
       
         The purpose of IFCs proposed financing is to support Genommas approximately US$232 million expansion plan over the next 2 years which includes the construction of Genommas first manufacturing facility in the state of Mexico, debt refinancing, and other capital expenditures (the Project).</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SII-40144" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2018-05-20" type="1"></activity-date>
  <activity-date iso-date="2018-07-02" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Genomma Lab Internacional S.A.B. de C.V.  Mr. Antonio Zamora Galland  Chief Financial Officer  +52 (55) 5081 0000  antonio.zamora@genommalab.com  Antonio Doval&#xED; Jaime No. 70, Torre C, Piso 2, despacho A Corporativo Samara, Col. Santa Fe, C.P. 01210.  Del. Alvaro Obreg&#xF3;n, M&#xE9;xico, D.F.  www.genommalab.com</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">p.cls-NormalWeb {
    margin-top:5pt;
    margin-bottom:5pt;
    text-align:left;
    font-family:&apos;Times New Roman&apos;, &apos;serif&apos;;
    font-size:12pt;
    line-height:108%;
    margin-left:0pt;
    margin-right:0pt;
}
span.cls-DefaultParagraphFont {
    font-family:&apos;Times New Roman&apos;, &apos;serif&apos;;
    font-size:12pt;
    font-weight:normal;
    margin:0in;
    padding:0in;
}
span.cls-DefaultParagraphFont-000000 {
    color:#000000;
    font-family:&apos;Times New Roman&apos;, &apos;serif&apos;;
    font-size:12pt;
    font-weight:normal;
    margin:0in;
    padding:0in;
}
p.cls-Normal {
    text-align:justify;
    font-family:&apos;Times New Roman&apos;, &apos;serif&apos;;
    font-size:12pt;
    line-height:108%;
    margin-top:0pt;
    margin-left:0pt;
    margin-right:0pt;
    margin-bottom:.001pt;
}
span.cls-Hyperlink {
    color:#0563C1;
    font-family:&apos;Times New Roman&apos;, &apos;serif&apos;;
    font-size:12pt;
    text-decoration:underline;
    font-weight:normal;
    margin:0in;
    padding:0in;
}
table { border-collapse:collapse !important; width:100%; table-layout:fixed; border-spacing:0 !important; margin-bottom:15px; } .k-table, .k-table td, table, table td, div table, div table td {outline: 0;border: 1px solid #000;} .k-table td, table td, div table td { padding: 5px;} 
   
   
     
       
         &#xA0; 
         Mr. Antonio Zamora Galland 
       
       
         Chief Financial Officer 
       
       
         Antonio Doval&#xED; Jaime No. 70, Torre C, Piso 2, despacho A Corporativo Samara, Col. Santa Fe, C.P. 01210. &#xA0;Del. Alvaro Obreg&#xF3;n, M&#xE9;xico, D.F. 
       
       
         Telephone: +52 (55) 5081 0000 
       
       
         Email:&#xA0; 
         
           
             antonio.zamora@genommalab.com 
           
         
       
       
         www.genommalab.com</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="MX" percentage="100">
   <narrative xml:lang="EN">Mexico</narrative>
  </recipient-country>
  <location ref="MX-Mexico">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">p.cls-NormalWeb {
    margin-top:5pt;
    margin-bottom:5pt;
    text-align:left;
    font-family:&apos;Times New Roman&apos;, &apos;serif&apos;;
    font-size:12pt;
    line-height:108%;
    margin-left:0pt;
    margin-right:0pt;
}
span.cls-DefaultParagraphFont {
    font-family:&apos;Times New Roman&apos;, &apos;serif&apos;;
    font-size:12pt;
    font-weight:normal;
    margin:0in;
    padding:0in;
}
table { border-collapse:collapse !important; width:100%; table-layout:fixed; border-spacing:0 !important; margin-bottom:15px; } .k-table, .k-table td, table, table td, div table, div table td {outline: 0;border: 1px solid #000;} .k-table td, table td, div table td { padding: 5px;} 
  
  
     
       
         The manufacturing to be supported through the Project will be located in San Cayetano de Morelos, Toluca, State of Mexico.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>23.0000000000 -102.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector code="325" percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">G-FA - Pharmaceuticals and Medicine Manufacturing</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $51.42 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2018-05-20"></period-start>
   <period-end iso-date="2018-06-30"></period-end>
   <value currency="USD" value-date="2018-05-20">51420000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-05-20"></transaction-date>
   <value currency="USD" value-date="2018-05-20">51420000</value>
   <receiver-org>
    <narrative xml:lang="EN">GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/40144/genomma-lab">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information - Anticipated Impact Measurement &amp; Monitoring (AIMM) Assessment and Main Environmental &amp; Social Risks and Impacts of the Project</narrative>
   </title>
   <category code="A01"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/40144/genomma-lab">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
